| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 02/23/2005 | EP1507781A2 Process for preparing maytansinol |
| 02/23/2005 | EP1507557A1 Methods and devices for targeting a site in a mammal and for removing species from a mammal |
| 02/23/2005 | EP1507556A2 Calicheamicin derivative-carrier conjugates |
| 02/23/2005 | EP1507548A1 Method for determining immune system affecting compounds |
| 02/23/2005 | EP1507546A2 Methods of using 22417, a novel human aminoprotease family member |
| 02/23/2005 | EP1187853B1 Diagnostic uses of antibodies against acetylcholinesterase or c-terminal peptides thereof |
| 02/23/2005 | EP1007570A4 Monospecific antibody reactive with fibrinogen and fibrinopeptide b |
| 02/23/2005 | CN1585822A Polycistronic expression of antibodies |
| 02/23/2005 | CN1585778A Modified anti-TNF alpha antibody |
| 02/23/2005 | CN1585776A Detection and identification of enteric bacteria |
| 02/23/2005 | CN1585651A Methods of sterilizing biological materials containing non-aqueous solvents |
| 02/23/2005 | CN1584028A Cloning for sifting tumor hecrosis target antibody, preparing method and use thereof |
| 02/23/2005 | CN1583792A Vitellus immune globulin for preventing prawn virus, tis preparing method and use thereof |
| 02/23/2005 | CN1583788A Tanscription activating factor genes of candida albicans and their use |
| 02/23/2005 | CN1583787A Stimulated polypeptide, its coding genes and use of capsule protein HVR1 of hepatitis C virus |
| 02/23/2005 | CN1190491C PRV-gene and use thereof |
| 02/23/2005 | CN1190446C New human protein with function of improving mouse NIH/3T3 cell transformation and its encoding sequence |
| 02/23/2005 | CN1190183C Safety toothpaste for preventing and curing oral cavity diseases |
| 02/22/2005 | US6858719 Rh(D)-binding proteins and magnetically activated cell sorting method for production thereof |
| 02/22/2005 | US6858716 Drosophila recombination-associated protein and methods for use |
| 02/22/2005 | US6858714 Cyclic GMP phosphodiesterase |
| 02/22/2005 | US6858712 Cloning and expression of HTLV-III DNA |
| 02/22/2005 | US6858710 Compositions and methods for the therapy and diagnosis of ovarian cancer |
| 02/22/2005 | US6858438 Peptides immunoreactive with autoantibodies from patients with rheumatoid arthritis |
| 02/22/2005 | US6858431 An osteoinductive soluble factor induced by the expression of human mineralization protein. |
| 02/22/2005 | US6858420 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 02/22/2005 | US6858418 Polypeptide for use in the treatment of cardiovascular and cell proliferation disorders |
| 02/22/2005 | US6858409 Identifying nucleotide sequences which code modulator for treating arthritis, inflammatory bowel, sepsis and adult respiratory distress diseases; immunosuppressant |
| 02/22/2005 | US6858407 Nucleotide sequences coding polypetide for use in the treatment, prevention and diagnosis of gastrointestinal and apoptosis disorders |
| 02/22/2005 | US6858402 System for discovering and producing polypeptides that cause TNF receptor shedding |
| 02/22/2005 | US6858397 Antibodies specific for native PrPsc |
| 02/22/2005 | US6858386 Using cancer marker protein to detect, classify, evaluate and prevent cell proliferative disorders |
| 02/22/2005 | US6858384 Isolation of bacteriophage from solution; obtain antibody library, incubate with target cells, separate target cell from phage particles, recover phage particles |
| 02/22/2005 | US6858383 Compositions and methods for the treatment and prevention of cardiovascular diseases and disorders, and for identifying agents therapeutic therefor |
| 02/22/2005 | US6858209 Means for detecting bacteria of the taylorella equigenitalis species and their biological applications |
| 02/22/2005 | US6858207 Methods and materials relating to novel CD39-like polypeptides |
| 02/22/2005 | CA2093022C Targeted immunostimulation with bispecific reagents |
| 02/17/2005 | WO2005014838A1 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/17/2005 | WO2005014819A1 Esophageal cancer antigen and utilization thereof |
| 02/17/2005 | WO2005014818A1 Gene overexpressed in cancer |
| 02/17/2005 | WO2005014801A1 Improvements in cell culture productivity |
| 02/17/2005 | WO2005014795A2 Osteoarthritis biomarkers and uses thereof |
| 02/17/2005 | WO2005014654A2 Product comprising a c4bp core protein and a monomeric antigen, and its use |
| 02/17/2005 | WO2005014653A2 Humanized chicken antibodies |
| 02/17/2005 | WO2005014652A1 A variant cell surface molecule associated with cancer |
| 02/17/2005 | WO2005014651A1 Sugar chain-modified anti-hm1.24 antibody |
| 02/17/2005 | WO2005014650A2 Antibodies specific for sclerostin and methods for increasing bone mineralization |
| 02/17/2005 | WO2005014649A2 Method for the preparation of molecules having antibody activity |
| 02/17/2005 | WO2005014645A2 Pedf-r receptor and uses |
| 02/17/2005 | WO2005014625A1 Polypeptides having brain disposition activity and utilization of the same |
| 02/17/2005 | WO2005014618A2 Bispecific antibodies for inducing apoptosis of tumor and diseased cells |
| 02/17/2005 | WO2005014039A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative diseases |
| 02/17/2005 | WO2005013918A2 Compositions, methods and kits relating to poxvirus subunit vaccines |
| 02/17/2005 | WO2005013915A2 Novel indications for transforming growth factor-beta regulators |
| 02/17/2005 | WO2005013912A2 Anti-fcrn antibodies for treatment of auto/allo immune conditions |
| 02/17/2005 | WO2005013899A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 02/17/2005 | WO2005013802A2 Trefoil factor 3 (tff3) as a target for anti-cancer therapy |
| 02/17/2005 | WO2005013800A2 Elevated hedgehog pathway activity in digestive system tumors, and methods of treating digestive system tumors having elevated hedgehog pathway activity |
| 02/17/2005 | WO2004108157A3 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 02/17/2005 | WO2004097009A3 METHOD TO IDENTIFY AGENTS THAT ACTIVATE OR INHIBIT IKKi |
| 02/17/2005 | WO2004091655A3 Immunogenic recombinant antibody |
| 02/17/2005 | WO2004087200B1 Vaccine and serum for protection of cystic fibrosis patients against pseudomonas aeruginosa |
| 02/17/2005 | WO2004081046A3 Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| 02/17/2005 | WO2004074455A3 Fc REGION VARIANTS |
| 02/17/2005 | WO2004074432A3 Antibody vaccine conjugates and uses therefor |
| 02/17/2005 | WO2004073319A3 Methods and compounds for raising antibodies and for screening antibody repertoires |
| 02/17/2005 | WO2004046310A3 Novel mouse polypeptides encoded by polynucleotides and methods of their use |
| 02/17/2005 | WO2004008099A8 METHODS FOR IDENTIFYING TUMORS THAT ARE RESPONSIVE TO TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 02/17/2005 | WO2004005457A3 Tfc/ beta-catenin regulated genes for treating cancer |
| 02/17/2005 | WO2003104425A3 Novel stable anti-cd22 antibodies |
| 02/17/2005 | WO2003091431A8 Methylotroph producing mammalian type sugar chain |
| 02/17/2005 | WO2003050258A3 Endogenous retrovirus polypeptides linked to oncogenic transformation |
| 02/17/2005 | WO2003025131A3 Protein modification and maintenance molecules |
| 02/17/2005 | WO2002074913A3 Nucleic acid-associated proteins |
| 02/17/2005 | US20050038232 Monoclonal antibody for use in detection and screening for biological warfare agents |
| 02/17/2005 | US20050038231 Using immunoafinity chromatography to isolate preferential polypeptides from solution |
| 02/17/2005 | US20050038229 Protein scaffolds for antibody mimics and other binding proteins |
| 02/17/2005 | US20050037965 Use of PAK inhibitor for the treatment of a joint disease |
| 02/17/2005 | US20050037955 Bactericides; fungicides; isolated polypeptides; inflammatory bowel disorders; infections |
| 02/17/2005 | US20050037464 Prokineticin polypeptides, related compositions and methods |
| 02/17/2005 | US20050037456 Purification of polypeptides |
| 02/17/2005 | US20050037448 C-peptide specific assay procedure |
| 02/17/2005 | US20050037446 Protein kinase binding modulator for use in treatment and prevention of cardiovascular, cell proliferative, neurodegenerative and bone disorders |
| 02/17/2005 | US20050037444 Method for identification isolation and production of antigens to a specific pathogen |
| 02/17/2005 | US20050037439 Differentially expressed genes involved in cancer, the polypeptides encoded thereby, and methods of using the same |
| 02/17/2005 | US20050037434 Immunolobulin which interferes with lysosome associated membrane protein 1(LAMP-1) ligand binding for use in treatment and prevention of autoimmune diabetes |
| 02/17/2005 | US20050037432 Macroglobulin peptides for use as diagnostic indicator of osteoarthritis, bone and tissue disorders |
| 02/17/2005 | US20050037421 Composition comprising mammalian variable heavy chain components for use as tool in immunotherapeutics and diagnostics |
| 02/17/2005 | US20050037420 Chimeric antibody fragments for use as tool in protein chip and tumor imaging; immunodiagnostics |
| 02/17/2005 | US20050037419 Compositions and methods relating to lung specific genes and proteins |
| 02/17/2005 | US20050037358 Converting immunoglobulin variable domain messenger RNA into CDNA using univversal primer, amplifying, inserting and replicating nucleotide sequences in vector and host cells; immunotherapy |
| 02/17/2005 | US20050037345 Gene with polynucleopotide codes with polypeptide with amino acid sequences for domains and molecular hybridization for gene expression and cancer |
| 02/17/2005 | US20050037340 Immunoglobulin for use in detection of simian and lymphadenopathy associated viral infection in mammals; immunodiagnostics |
| 02/17/2005 | US20050037339 Methods of selecting internalizing antibodies |
| 02/17/2005 | US20050037336 Hepatitis X virus for use in generation of antibody and vaccine compositions for use in diagnosis, prevention and treatment viral infection; immunotherapeutic and diagnostics |
| 02/17/2005 | US20050037061 Remedies for mammary cancer |
| 02/17/2005 | US20050037027 Mycoplasma vaccine, method of making, and application thereof |
| 02/17/2005 | US20050037026 such as Alzheimer's disease; amyloid precursor proteins; comprises diphtheria toxoid as carrier |
| 02/17/2005 | US20050037010 Compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer |
| 02/17/2005 | US20050037008 unexpected discovery that the inhibition or antagonism of TNF decreases the expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF). VEGF has been implicated in the angiogenesis in cancer, vascular diseases and rheumatoid arthritis |